Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13
Original Research
Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,240 | Dovepress* | 6,507+ | 1,075 | 7,582 | |
| PubMed Central* | 733 | 243 | 976 | ||
| Totals | 7,240 | 1,318 | 8,558 | ||
| *Since 18 October 2018 | |||||
View citations on PubMed Central and Google Scholar